14226
These agents include newer incretin - based therapies and PPAR agonists , as well as new therapeutic classes such as sodium - coupled glucose cotransporter 2 inhibitors , free fatty acid receptor agonists , 11 - beta - hydroxysteroid dehydrogenase type 1 inhibitors , glucokinase activators , and several others that may enter clinical use over the next decade .
 Chemical: sodium; Chemical: glucose; Chemical: fatty acid; Chemical: 11 - beta - hydroxysteroid
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Chemical 
Text: {0} 
Answer:
 Chemical: sodium; Chemical: glucose; Chemical: fatty acid; Chemical: 11 - beta - hydroxysteroid